img

Global Non-opioid Pain Patch Market Research Report 2024

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Non-opioid Pain Patch Market Research Report 2024

A non-opioid pain patch is a medicated adhesive patch that is placed on the skin to deliver a specific dose of medication through the skin and into the bloodstream. Often, this promotes healing to an injured area of the body. An advantage of a transdermal drug delivery route over other types of medication delivery such as oral, topical, intravenous, intramuscular, etc. is that the patch provides a controlled release of the medication into the patient, usually through either a porous membrane covering a reservoir of medication or through body heat melting thin layers of medication embedded in the adhesive.
According to Mr Accuracy reports’s new survey, global Non-opioid Pain Patch market is projected to reach US$ 779.5 million in 2034, increasing from US$ 631.4 million in 2024, with the CAGR of 2.6% during the period of 2023 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Non-opioid Pain Patch market research.
Key manufacturers engaged in the Non-opioid Pain Patch industry include Hisamitsu, Mylan, Johnson & Johnson, Actavis, Lingrui, Teikoku Seiyaku, Sanofi, Novartis and Qizheng, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2024.
When refers to consumption region, % volume of Non-opioid Pain Patch were sold to North America, Europe and Asia Pacific in 2024. Moreover, China, plays a key role in the whole Non-opioid Pain Patch market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2024) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Non-opioid Pain Patch market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Hisamitsu
Mylan
Johnson & Johnson
Actavis
Lingrui
Teikoku Seiyaku
Sanofi
Novartis
Qizheng
Endo
Huarun 999
GSK
Haw Par
Nichiban
Mentholatum
Laboratoires Genevrier
BLUE-EMU
Segment by Type
Lidocaine Patches
Diclofenac Patches
Indomethacin Patches
Counter-Irritant Patches
Fentanyl Patches
Others

Segment by Application


OTC
Rx

Consumption by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Non-opioid Pain Patch report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source

Table of Content

1 Non-opioid Pain Patch Market Overview
1.1 Product Overview and Scope of Non-opioid Pain Patch
1.2 Non-opioid Pain Patch Segment by Type
1.2.1 Global Non-opioid Pain Patch Market Value Comparison by Type (2024-2034)
1.2.2 Lidocaine Patches
1.2.3 Diclofenac Patches
1.2.4 Indomethacin Patches
1.2.5 Counter-Irritant Patches
1.2.6 Fentanyl Patches
1.2.7 Others
1.3 Non-opioid Pain Patch Segment by Application
1.3.1 Global Non-opioid Pain Patch Market Value by Application: (2024-2034)
1.3.2 OTC
1.3.3 Rx
1.4 Global Non-opioid Pain Patch Market Size Estimates and Forecasts
1.4.1 Global Non-opioid Pain Patch Revenue 2018-2034
1.4.2 Global Non-opioid Pain Patch Sales 2018-2034
1.4.3 Global Non-opioid Pain Patch Market Average Price (2018-2034)
1.5 Assumptions and Limitations
2 Non-opioid Pain Patch Market Competition by Manufacturers
2.1 Global Non-opioid Pain Patch Sales Market Share by Manufacturers (2018-2023)
2.2 Global Non-opioid Pain Patch Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Non-opioid Pain Patch Average Price by Manufacturers (2018-2023)
2.4 Global Non-opioid Pain Patch Industry Ranking 2021 VS 2024 VS 2023
2.5 Global Key Manufacturers of Non-opioid Pain Patch, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Non-opioid Pain Patch, Product Type & Application
2.7 Non-opioid Pain Patch Market Competitive Situation and Trends
2.7.1 Non-opioid Pain Patch Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Non-opioid Pain Patch Players Market Share by Revenue
2.7.3 Global Non-opioid Pain Patch Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Non-opioid Pain Patch Retrospective Market Scenario by Region
3.1 Global Non-opioid Pain Patch Market Size by Region: 2018 Versus 2024 Versus 2034
3.2 Global Non-opioid Pain Patch Global Non-opioid Pain Patch Sales by Region: 2018-2034
3.2.1 Global Non-opioid Pain Patch Sales by Region: 2018-2023
3.2.2 Global Non-opioid Pain Patch Sales by Region: 2024-2034
3.3 Global Non-opioid Pain Patch Global Non-opioid Pain Patch Revenue by Region: 2018-2034
3.3.1 Global Non-opioid Pain Patch Revenue by Region: 2018-2023
3.3.2 Global Non-opioid Pain Patch Revenue by Region: 2024-2034
3.4 North America Non-opioid Pain Patch Market Facts & Figures by Country
3.4.1 North America Non-opioid Pain Patch Market Size by Country: 2018 VS 2024 VS 2034
3.4.2 North America Non-opioid Pain Patch Sales by Country (2018-2034)
3.4.3 North America Non-opioid Pain Patch Revenue by Country (2018-2034)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Non-opioid Pain Patch Market Facts & Figures by Country
3.5.1 Europe Non-opioid Pain Patch Market Size by Country: 2018 VS 2024 VS 2034
3.5.2 Europe Non-opioid Pain Patch Sales by Country (2018-2034)
3.5.3 Europe Non-opioid Pain Patch Revenue by Country (2018-2034)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Non-opioid Pain Patch Market Facts & Figures by Country
3.6.1 Asia Pacific Non-opioid Pain Patch Market Size by Country: 2018 VS 2024 VS 2034
3.6.2 Asia Pacific Non-opioid Pain Patch Sales by Country (2018-2034)
3.6.3 Asia Pacific Non-opioid Pain Patch Revenue by Country (2018-2034)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Non-opioid Pain Patch Market Facts & Figures by Country
3.7.1 Latin America Non-opioid Pain Patch Market Size by Country: 2018 VS 2024 VS 2034
3.7.2 Latin America Non-opioid Pain Patch Sales by Country (2018-2034)
3.7.3 Latin America Non-opioid Pain Patch Revenue by Country (2018-2034)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Non-opioid Pain Patch Market Facts & Figures by Country
3.8.1 Middle East and Africa Non-opioid Pain Patch Market Size by Country: 2018 VS 2024 VS 2034
3.8.2 Middle East and Africa Non-opioid Pain Patch Sales by Country (2018-2034)
3.8.3 Middle East and Africa Non-opioid Pain Patch Revenue by Country (2018-2034)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Non-opioid Pain Patch Sales by Type (2018-2034)
4.1.1 Global Non-opioid Pain Patch Sales by Type (2018-2023)
4.1.2 Global Non-opioid Pain Patch Sales by Type (2024-2034)
4.1.3 Global Non-opioid Pain Patch Sales Market Share by Type (2018-2034)
4.2 Global Non-opioid Pain Patch Revenue by Type (2018-2034)
4.2.1 Global Non-opioid Pain Patch Revenue by Type (2018-2023)
4.2.2 Global Non-opioid Pain Patch Revenue by Type (2024-2034)
4.2.3 Global Non-opioid Pain Patch Revenue Market Share by Type (2018-2034)
4.3 Global Non-opioid Pain Patch Price by Type (2018-2034)
5 Segment by Application
5.1 Global Non-opioid Pain Patch Sales by Application (2018-2034)
5.1.1 Global Non-opioid Pain Patch Sales by Application (2018-2023)
5.1.2 Global Non-opioid Pain Patch Sales by Application (2024-2034)
5.1.3 Global Non-opioid Pain Patch Sales Market Share by Application (2018-2034)
5.2 Global Non-opioid Pain Patch Revenue by Application (2018-2034)
5.2.1 Global Non-opioid Pain Patch Revenue by Application (2018-2023)
5.2.2 Global Non-opioid Pain Patch Revenue by Application (2024-2034)
5.2.3 Global Non-opioid Pain Patch Revenue Market Share by Application (2018-2034)
5.3 Global Non-opioid Pain Patch Price by Application (2018-2034)
6 Key Companies Profiled
6.1 Hisamitsu
6.1.1 Hisamitsu Corporation Information
6.1.2 Hisamitsu Description and Business Overview
6.1.3 Hisamitsu Non-opioid Pain Patch Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Hisamitsu Non-opioid Pain Patch Product Portfolio
6.1.5 Hisamitsu Recent Developments/Updates
6.2 Mylan
6.2.1 Mylan Corporation Information
6.2.2 Mylan Description and Business Overview
6.2.3 Mylan Non-opioid Pain Patch Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Mylan Non-opioid Pain Patch Product Portfolio
6.2.5 Mylan Recent Developments/Updates
6.3 Johnson & Johnson
6.3.1 Johnson & Johnson Corporation Information
6.3.2 Johnson & Johnson Description and Business Overview
6.3.3 Johnson & Johnson Non-opioid Pain Patch Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Johnson & Johnson Non-opioid Pain Patch Product Portfolio
6.3.5 Johnson & Johnson Recent Developments/Updates
6.4 Actavis
6.4.1 Actavis Corporation Information
6.4.2 Actavis Description and Business Overview
6.4.3 Actavis Non-opioid Pain Patch Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Actavis Non-opioid Pain Patch Product Portfolio
6.4.5 Actavis Recent Developments/Updates
6.5 Lingrui
6.5.1 Lingrui Corporation Information
6.5.2 Lingrui Description and Business Overview
6.5.3 Lingrui Non-opioid Pain Patch Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Lingrui Non-opioid Pain Patch Product Portfolio
6.5.5 Lingrui Recent Developments/Updates
6.6 Teikoku Seiyaku
6.6.1 Teikoku Seiyaku Corporation Information
6.6.2 Teikoku Seiyaku Description and Business Overview
6.6.3 Teikoku Seiyaku Non-opioid Pain Patch Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Teikoku Seiyaku Non-opioid Pain Patch Product Portfolio
6.6.5 Teikoku Seiyaku Recent Developments/Updates
6.7 Sanofi
6.6.1 Sanofi Corporation Information
6.6.2 Sanofi Description and Business Overview
6.6.3 Sanofi Non-opioid Pain Patch Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Sanofi Non-opioid Pain Patch Product Portfolio
6.7.5 Sanofi Recent Developments/Updates
6.8 Novartis
6.8.1 Novartis Corporation Information
6.8.2 Novartis Description and Business Overview
6.8.3 Novartis Non-opioid Pain Patch Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Novartis Non-opioid Pain Patch Product Portfolio
6.8.5 Novartis Recent Developments/Updates
6.9 Qizheng
6.9.1 Qizheng Corporation Information
6.9.2 Qizheng Description and Business Overview
6.9.3 Qizheng Non-opioid Pain Patch Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Qizheng Non-opioid Pain Patch Product Portfolio
6.9.5 Qizheng Recent Developments/Updates
6.10 Endo
6.10.1 Endo Corporation Information
6.10.2 Endo Description and Business Overview
6.10.3 Endo Non-opioid Pain Patch Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Endo Non-opioid Pain Patch Product Portfolio
6.10.5 Endo Recent Developments/Updates
6.11 Huarun 999
6.11.1 Huarun 999 Corporation Information
6.11.2 Huarun 999 Non-opioid Pain Patch Description and Business Overview
6.11.3 Huarun 999 Non-opioid Pain Patch Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Huarun 999 Non-opioid Pain Patch Product Portfolio
6.11.5 Huarun 999 Recent Developments/Updates
6.12 GSK
6.12.1 GSK Corporation Information
6.12.2 GSK Non-opioid Pain Patch Description and Business Overview
6.12.3 GSK Non-opioid Pain Patch Sales, Revenue and Gross Margin (2018-2023)
6.12.4 GSK Non-opioid Pain Patch Product Portfolio
6.12.5 GSK Recent Developments/Updates
6.13 Haw Par
6.13.1 Haw Par Corporation Information
6.13.2 Haw Par Non-opioid Pain Patch Description and Business Overview
6.13.3 Haw Par Non-opioid Pain Patch Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Haw Par Non-opioid Pain Patch Product Portfolio
6.13.5 Haw Par Recent Developments/Updates
6.14 Nichiban
6.14.1 Nichiban Corporation Information
6.14.2 Nichiban Non-opioid Pain Patch Description and Business Overview
6.14.3 Nichiban Non-opioid Pain Patch Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Nichiban Non-opioid Pain Patch Product Portfolio
6.14.5 Nichiban Recent Developments/Updates
6.15 Mentholatum
6.15.1 Mentholatum Corporation Information
6.15.2 Mentholatum Non-opioid Pain Patch Description and Business Overview
6.15.3 Mentholatum Non-opioid Pain Patch Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Mentholatum Non-opioid Pain Patch Product Portfolio
6.15.5 Mentholatum Recent Developments/Updates
6.16 Laboratoires Genevrier
6.16.1 Laboratoires Genevrier Corporation Information
6.16.2 Laboratoires Genevrier Non-opioid Pain Patch Description and Business Overview
6.16.3 Laboratoires Genevrier Non-opioid Pain Patch Sales, Revenue and Gross Margin (2018-2023)
6.16.4 Laboratoires Genevrier Non-opioid Pain Patch Product Portfolio
6.16.5 Laboratoires Genevrier Recent Developments/Updates
6.17 BLUE-EMU
6.17.1 BLUE-EMU Corporation Information
6.17.2 BLUE-EMU Non-opioid Pain Patch Description and Business Overview
6.17.3 BLUE-EMU Non-opioid Pain Patch Sales, Revenue and Gross Margin (2018-2023)
6.17.4 BLUE-EMU Non-opioid Pain Patch Product Portfolio
6.17.5 BLUE-EMU Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Non-opioid Pain Patch Industry Chain Analysis
7.2 Non-opioid Pain Patch Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Non-opioid Pain Patch Production Mode & Process
7.4 Non-opioid Pain Patch Sales and Marketing
7.4.1 Non-opioid Pain Patch Sales Channels
7.4.2 Non-opioid Pain Patch Distributors
7.5 Non-opioid Pain Patch Customers
8 Non-opioid Pain Patch Market Dynamics
8.1 Non-opioid Pain Patch Industry Trends
8.2 Non-opioid Pain Patch Market Drivers
8.3 Non-opioid Pain Patch Market Challenges
8.4 Non-opioid Pain Patch Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Non-opioid Pain Patch Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Non-opioid Pain Patch Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Non-opioid Pain Patch Market Competitive Situation by Manufacturers in 2024
Table 4. Global Non-opioid Pain Patch Sales (M Units) of Key Manufacturers (2018-2023)
Table 5. Global Non-opioid Pain Patch Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Non-opioid Pain Patch Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Non-opioid Pain Patch Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Non-opioid Pain Patch Average Price (USD/K Units) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Non-opioid Pain Patch, Industry Ranking, 2021 VS 2024 VS 2023
Table 10. Global Key Manufacturers of Non-opioid Pain Patch, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Non-opioid Pain Patch, Product Type & Application
Table 12. Global Key Manufacturers of Non-opioid Pain Patch, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Non-opioid Pain Patch by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-opioid Pain Patch as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Non-opioid Pain Patch Market Size by Region (US$ Million): 2018 VS 2024 VS 2034
Table 17. Global Non-opioid Pain Patch Sales by Region (2018-2023) & (M Units)
Table 18. Global Non-opioid Pain Patch Sales Market Share by Region (2018-2023)
Table 19. Global Non-opioid Pain Patch Sales by Region (2024-2034) & (M Units)
Table 20. Global Non-opioid Pain Patch Sales Market Share by Region (2024-2034)
Table 21. Global Non-opioid Pain Patch Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Non-opioid Pain Patch Revenue Market Share by Region (2018-2023)
Table 23. Global Non-opioid Pain Patch Revenue by Region (2024-2034) & (US$ Million)
Table 24. Global Non-opioid Pain Patch Revenue Market Share by Region (2024-2034)
Table 25. North America Non-opioid Pain Patch Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 26. North America Non-opioid Pain Patch Sales by Country (2018-2023) & (M Units)
Table 27. North America Non-opioid Pain Patch Sales by Country (2024-2034) & (M Units)
Table 28. North America Non-opioid Pain Patch Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Non-opioid Pain Patch Revenue by Country (2024-2034) & (US$ Million)
Table 30. Europe Non-opioid Pain Patch Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 31. Europe Non-opioid Pain Patch Sales by Country (2018-2023) & (M Units)
Table 32. Europe Non-opioid Pain Patch Sales by Country (2024-2034) & (M Units)
Table 33. Europe Non-opioid Pain Patch Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Non-opioid Pain Patch Revenue by Country (2024-2034) & (US$ Million)
Table 35. Asia Pacific Non-opioid Pain Patch Revenue by Region: 2018 VS 2024 VS 2034 (US$ Million)
Table 36. Asia Pacific Non-opioid Pain Patch Sales by Region (2018-2023) & (M Units)
Table 37. Asia Pacific Non-opioid Pain Patch Sales by Region (2024-2034) & (M Units)
Table 38. Asia Pacific Non-opioid Pain Patch Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Non-opioid Pain Patch Revenue by Region (2024-2034) & (US$ Million)
Table 40. Latin America Non-opioid Pain Patch Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 41. Latin America Non-opioid Pain Patch Sales by Country (2018-2023) & (M Units)
Table 42. Latin America Non-opioid Pain Patch Sales by Country (2024-2034) & (M Units)
Table 43. Latin America Non-opioid Pain Patch Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Non-opioid Pain Patch Revenue by Country (2024-2034) & (US$ Million)
Table 45. Middle East & Africa Non-opioid Pain Patch Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 46. Middle East & Africa Non-opioid Pain Patch Sales by Country (2018-2023) & (M Units)
Table 47. Middle East & Africa Non-opioid Pain Patch Sales by Country (2024-2034) & (M Units)
Table 48. Middle East & Africa Non-opioid Pain Patch Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Non-opioid Pain Patch Revenue by Country (2024-2034) & (US$ Million)
Table 50. Global Non-opioid Pain Patch Sales (M Units) by Type (2018-2023)
Table 51. Global Non-opioid Pain Patch Sales (M Units) by Type (2024-2034)
Table 52. Global Non-opioid Pain Patch Sales Market Share by Type (2018-2023)
Table 53. Global Non-opioid Pain Patch Sales Market Share by Type (2024-2034)
Table 54. Global Non-opioid Pain Patch Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Non-opioid Pain Patch Revenue (US$ Million) by Type (2024-2034)
Table 56. Global Non-opioid Pain Patch Revenue Market Share by Type (2018-2023)
Table 57. Global Non-opioid Pain Patch Revenue Market Share by Type (2024-2034)
Table 58. Global Non-opioid Pain Patch Price (USD/K Units) by Type (2018-2023)
Table 59. Global Non-opioid Pain Patch Price (USD/K Units) by Type (2024-2034)
Table 60. Global Non-opioid Pain Patch Sales (M Units) by Application (2018-2023)
Table 61. Global Non-opioid Pain Patch Sales (M Units) by Application (2024-2034)
Table 62. Global Non-opioid Pain Patch Sales Market Share by Application (2018-2023)
Table 63. Global Non-opioid Pain Patch Sales Market Share by Application (2024-2034)
Table 64. Global Non-opioid Pain Patch Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Non-opioid Pain Patch Revenue (US$ Million) by Application (2024-2034)
Table 66. Global Non-opioid Pain Patch Revenue Market Share by Application (2018-2023)
Table 67. Global Non-opioid Pain Patch Revenue Market Share by Application (2024-2034)
Table 68. Global Non-opioid Pain Patch Price (USD/K Units) by Application (2018-2023)
Table 69. Global Non-opioid Pain Patch Price (USD/K Units) by Application (2024-2034)
Table 70. Hisamitsu Corporation Information
Table 71. Hisamitsu Description and Business Overview
Table 72. Hisamitsu Non-opioid Pain Patch Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2018-2023)
Table 73. Hisamitsu Non-opioid Pain Patch Product
Table 74. Hisamitsu Recent Developments/Updates
Table 75. Mylan Corporation Information
Table 76. Mylan Description and Business Overview
Table 77. Mylan Non-opioid Pain Patch Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2018-2023)
Table 78. Mylan Non-opioid Pain Patch Product
Table 79. Mylan Recent Developments/Updates
Table 80. Johnson & Johnson Corporation Information
Table 81. Johnson & Johnson Description and Business Overview
Table 82. Johnson & Johnson Non-opioid Pain Patch Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2018-2023)
Table 83. Johnson & Johnson Non-opioid Pain Patch Product
Table 84. Johnson & Johnson Recent Developments/Updates
Table 85. Actavis Corporation Information
Table 86. Actavis Description and Business Overview
Table 87. Actavis Non-opioid Pain Patch Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2018-2023)
Table 88. Actavis Non-opioid Pain Patch Product
Table 89. Actavis Recent Developments/Updates
Table 90. Lingrui Corporation Information
Table 91. Lingrui Description and Business Overview
Table 92. Lingrui Non-opioid Pain Patch Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2018-2023)
Table 93. Lingrui Non-opioid Pain Patch Product
Table 94. Lingrui Recent Developments/Updates
Table 95. Teikoku Seiyaku Corporation Information
Table 96. Teikoku Seiyaku Description and Business Overview
Table 97. Teikoku Seiyaku Non-opioid Pain Patch Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2018-2023)
Table 98. Teikoku Seiyaku Non-opioid Pain Patch Product
Table 99. Teikoku Seiyaku Recent Developments/Updates
Table 100. Sanofi Corporation Information
Table 101. Sanofi Description and Business Overview
Table 102. Sanofi Non-opioid Pain Patch Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2018-2023)
Table 103. Sanofi Non-opioid Pain Patch Product
Table 104. Sanofi Recent Developments/Updates
Table 105. Novartis Corporation Information
Table 106. Novartis Description and Business Overview
Table 107. Novartis Non-opioid Pain Patch Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2018-2023)
Table 108. Novartis Non-opioid Pain Patch Product
Table 109. Novartis Recent Developments/Updates
Table 110. Qizheng Corporation Information
Table 111. Qizheng Description and Business Overview
Table 112. Qizheng Non-opioid Pain Patch Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2018-2023)
Table 113. Qizheng Non-opioid Pain Patch Product
Table 114. Qizheng Recent Developments/Updates
Table 115. Endo Corporation Information
Table 116. Endo Description and Business Overview
Table 117. Endo Non-opioid Pain Patch Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2018-2023)
Table 118. Endo Non-opioid Pain Patch Product
Table 119. Endo Recent Developments/Updates
Table 120. Huarun 999 Corporation Information
Table 121. Huarun 999 Description and Business Overview
Table 122. Huarun 999 Non-opioid Pain Patch Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2018-2023)
Table 123. Huarun 999 Non-opioid Pain Patch Product
Table 124. Huarun 999 Recent Developments/Updates
Table 125. GSK Corporation Information
Table 126. GSK Description and Business Overview
Table 127. GSK Non-opioid Pain Patch Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2018-2023)
Table 128. GSK Non-opioid Pain Patch Product
Table 129. GSK Recent Developments/Updates
Table 130. Haw Par Corporation Information
Table 131. Haw Par Description and Business Overview
Table 132. Haw Par Non-opioid Pain Patch Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2018-2023)
Table 133. Haw Par Non-opioid Pain Patch Product
Table 134. Haw Par Recent Developments/Updates
Table 135. Nichiban Corporation Information
Table 136. Nichiban Description and Business Overview
Table 137. Nichiban Non-opioid Pain Patch Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2018-2023)
Table 138. Nichiban Non-opioid Pain Patch Product
Table 139. Nichiban Recent Developments/Updates
Table 140. Mentholatum Corporation Information
Table 141. Mentholatum Description and Business Overview
Table 142. Mentholatum Non-opioid Pain Patch Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2018-2023)
Table 143. Mentholatum Non-opioid Pain Patch Product
Table 144. Mentholatum Recent Developments/Updates
Table 145. Laboratoires Genevrier Corporation Information
Table 146. Laboratoires Genevrier Description and Business Overview
Table 147. Laboratoires Genevrier Non-opioid Pain Patch Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2018-2023)
Table 148. Laboratoires Genevrier Non-opioid Pain Patch Product
Table 149. Laboratoires Genevrier Recent Developments/Updates
Table 150. BLUE-EMU Corporation Information
Table 151. BLUE-EMU Description and Business Overview
Table 152. BLUE-EMU Non-opioid Pain Patch Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2018-2023)
Table 153. BLUE-EMU Non-opioid Pain Patch Product
Table 154. BLUE-EMU Recent Developments/Updates
Table 155. Key Raw Materials Lists
Table 156. Raw Materials Key Suppliers Lists
Table 157. Non-opioid Pain Patch Distributors List
Table 158. Non-opioid Pain Patch Customers List
Table 159. Non-opioid Pain Patch Market Trends
Table 160. Non-opioid Pain Patch Market Drivers
Table 161. Non-opioid Pain Patch Market Challenges
Table 162. Non-opioid Pain Patch Market Restraints
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Non-opioid Pain Patch
Figure 2. Global Non-opioid Pain Patch Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Non-opioid Pain Patch Market Share by Type in 2024 & 2034
Figure 4. Lidocaine Patches Product Picture
Figure 5. Diclofenac Patches Product Picture
Figure 6. Indomethacin Patches Product Picture
Figure 7. Counter-Irritant Patches Product Picture
Figure 8. Fentanyl Patches Product Picture
Figure 9. Others Product Picture
Figure 10. Global Non-opioid Pain Patch Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 11. Global Non-opioid Pain Patch Market Share by Application in 2024 & 2034
Figure 12. OTC
Figure 13. Rx
Figure 14. Global Non-opioid Pain Patch Revenue, (US$ Million), 2018 VS 2024 VS 2034
Figure 15. Global Non-opioid Pain Patch Market Size (2018-2034) & (US$ Million)
Figure 16. Global Non-opioid Pain Patch Sales (2018-2034) & (M Units)
Figure 17. Global Non-opioid Pain Patch Average Price (USD/K Units) & (2018-2034)
Figure 18. Non-opioid Pain Patch Report Years Considered
Figure 19. Non-opioid Pain Patch Sales Share by Manufacturers in 2024
Figure 20. Global Non-opioid Pain Patch Revenue Share by Manufacturers in 2024
Figure 21. The Global 5 and 10 Largest Non-opioid Pain Patch Players: Market Share by Revenue in 2024
Figure 22. Non-opioid Pain Patch Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2024
Figure 23. Global Non-opioid Pain Patch Market Size by Region (US$ Million): 2018 VS 2024 VS 2034
Figure 24. North America Non-opioid Pain Patch Sales Market Share by Country (2018-2034)
Figure 25. North America Non-opioid Pain Patch Revenue Market Share by Country (2018-2034)
Figure 26. U.S. Non-opioid Pain Patch Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 27. Canada Non-opioid Pain Patch Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 28. Europe Non-opioid Pain Patch Sales Market Share by Country (2018-2034)
Figure 29. Europe Non-opioid Pain Patch Revenue Market Share by Country (2018-2034)
Figure 30. Germany Non-opioid Pain Patch Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 31. France Non-opioid Pain Patch Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 32. U.K. Non-opioid Pain Patch Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 33. Italy Non-opioid Pain Patch Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 34. Russia Non-opioid Pain Patch Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 35. Asia Pacific Non-opioid Pain Patch Sales Market Share by Region (2018-2034)
Figure 36. Asia Pacific Non-opioid Pain Patch Revenue Market Share by Region (2018-2034)
Figure 37. China Non-opioid Pain Patch Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 38. Japan Non-opioid Pain Patch Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 39. South Korea Non-opioid Pain Patch Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 40. India Non-opioid Pain Patch Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 41. Australia Non-opioid Pain Patch Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 42. Taiwan Non-opioid Pain Patch Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 43. Indonesia Non-opioid Pain Patch Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 44. Thailand Non-opioid Pain Patch Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 45. Malaysia Non-opioid Pain Patch Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 46. Philippines Non-opioid Pain Patch Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 47. Latin America Non-opioid Pain Patch Sales Market Share by Country (2018-2034)
Figure 48. Latin America Non-opioid Pain Patch Revenue Market Share by Country (2018-2034)
Figure 49. Mexico Non-opioid Pain Patch Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 50. Brazil Non-opioid Pain Patch Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 51. Argentina Non-opioid Pain Patch Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 52. Middle East & Africa Non-opioid Pain Patch Sales Market Share by Country (2018-2034)
Figure 53. Middle East & Africa Non-opioid Pain Patch Revenue Market Share by Country (2018-2034)
Figure 54. Turkey Non-opioid Pain Patch Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 55. Saudi Arabia Non-opioid Pain Patch Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 56. UAE Non-opioid Pain Patch Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 57. Global Sales Market Share of Non-opioid Pain Patch by Type (2018-2034)
Figure 58. Global Revenue Market Share of Non-opioid Pain Patch by Type (2018-2034)
Figure 59. Global Non-opioid Pain Patch Price (USD/K Units) by Type (2018-2034)
Figure 60. Global Sales Market Share of Non-opioid Pain Patch by Application (2018-2034)
Figure 61. Global Revenue Market Share of Non-opioid Pain Patch by Application (2018-2034)
Figure 62. Global Non-opioid Pain Patch Price (USD/K Units) by Application (2018-2034)
Figure 63. Non-opioid Pain Patch Value Chain
Figure 64. Non-opioid Pain Patch Production Process
Figure 65. Channels of Distribution (Direct Vs Distribution)
Figure 66. Distributors Profiles
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries